ABSTRACT
Objective:To investigate the epidemiological characteristics and prognostic affecting factors of non-small cell lung cancer (NSCLC) in Shanxi from 2015 to 2019.Methods:A total of 17 082 patients with NSCLC in Shanxi Provincial Cancer Hospital from January 2015 to December 2019 were selected as the research subjects. The medical records of all patients were retrieved, and the epidemiological characteristics of the patients' age, gender, occupation and smoking history were analyzed. All patients were given conventional treatment and followed up for 18 months. According to the follow-up results, they were divided into the death group (4 391 cases) and the survival group (12 691 cases). The single factor and multivariate logistic regression analysis was used to analyze the factors affecting the prognosis of patients.Results:Among 17 082 patients with NSCLC, there were 3 058 cases (17.91%) in 2015, 3 129 cases (18.32%) in 2016, 3 325 cases (19.46%) in 2017, 3 564 cases (20.86%) in 2018, and 4 006 cases (23.45%) in 2019, and the number of confirmed cases in different years showed an upward trend ( χ2 = 21.593, P < 0.05). The incidence rate of males was slightly higher than that of females [51.76% (8 841/17 082) vs. 48.24% (8 241/17 082)], 64.12% (10 953/17 082) occurred in the 61-80 years old population, and the occupational distribution was predominantly workers [34.08% (5 821/17 082)] and farmers [30.00% (5 124/17 082)]; there were 56.69% (9 683/17 082) patients with a history of smoking. Multivariate logistic regression analysis showed that lymph node metastasis, tumor staging Ⅲ-Ⅳ, sensitive mutations of epidermal growth factor receptor, and initial pleural effusion were independent factors influencing the poor prognosis of patients with NSCLC (all P < 0.05). Conclusions:The incidence of NSCLC in Shanxi from 2015 to 2019 is on the rise. The incidence of this disease is related to gender, age and occupation. There are many factors affecting the prognosis of patients, and targeted interventions can help improve the prognosis.
ABSTRACT
Breast cancer stem cells (CSCs) are the main causes leading to the failure of treatment of breast cancer and play important roles in the progression of breast cancer and drug resistance, which are closely related to the therapeutic resistance of radiotherapy and chemotherapy, and endocrine therapy.The metastatic potential and therapeutic resistance of CSCs are associated with epithelial mesenchymal transition and Hedgehog, Wnt, interleukin-6/signal transduction and tanscriptional activation factor 3, transforming growth factor-β and other signaling pathways.While some of the targeted drugs targeting these signaling pathways are undergoing clinical transformation, which is expected to provide new approach for the clinical treatment of breast cancer.